#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucous membrane pemphigoid Astrocytoma malignant Alport's syndrome Pleural mesothelioma Adrenocortical carcinoma Lymphangioma Cerebral amyloid angiopathy B-cell lymphoma recurrent Inborn error of metabolism Acute graft versus host disease in skin Paraganglion neoplasm Acute respiratory distress syndrome Pancreatic carcinoma metastatic Congenital ectodermal dysplasia Mantle cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Basic Information Haemophagocytic lymphohistiocytosis – Basic Information Mantle cell lymphoma Ewing’s sarcoma – Life with Disease Stevens-Johnson syndrome – Treatment Hypereosinophilic syndrome – Diagnostics Idiopathic pulmonary fibrosis – Diagnostics Pleural mesothelioma malignant – Diagnostics Systemic mastocytosis – Diagnostics Tuberous sclerosis complex – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    A/(H3N2)-LIKE VIRUS ANTIGEN Taxanes Inaxaplin ALPROSTADIL HUMAN THROMBIN SECRETIN SYNTHETIC HUMAN Cetrorelix Revumenib Tas3351 Betamethasone Valerate Desogestrel Bi 685509 Rbl035.2 Deupirfenidone Gadoxetic Acid, Disodium RNMB1 Gadoquatrane Specific Nucleic Acid Sna-Papi Dexamethasone Acetate Ph. Eur. ASP3082 More therapies…

    Learn about Your Condition

    Obstructive pancreatitis Acquired ATTR amyloidosis Dermatitis Follicular thyroid cancer Prodromal Alzheimer's disease Colitis ulcerative Andersen-Tawil syndrome Meniere's disease Medullary thyroid cancer Muscle injury Tendon disorder Glioblastoma Systemic scleroderma Myopia Rabies More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • 5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One
    • Enzalutamide
    Bulgaria Czechia Denmark Finland France Germany +8

  • Study on Fluorescence-Guided Surgery Using cRGD-ZW800-1 for Patients with Laryngeal and Hypopharyngeal Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Crgd-Zw800-1
    The Netherlands

  • Study on Abatacept for Predicting Treatment Response in Patients with Early Rheumatoid Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    Belgium Italy The Netherlands Portugal Spain

  • Study on the Effect of Human Serum Albumin in Critically Ill Patients with Septic Shock at High Risk of Acute Kidney Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    • Acute kidney injury
    Investigated Drugs:
    • Human Serum Albumin
    Spain

  • Study of DNAJB1-PRKACA Peptide Vaccine for Patients with Fibrolamellar Hepatocellular Carcinoma and Other Tumors with Oncogenic Driver Fusion

    Recruiting

    1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Germany

  • Study on Verapamil to Preserve Insulin Secretion in Children with Recent Onset Type 1 Diabetes

    Recruiting

    1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Verapamil
    Sweden
Previous Page
1 … 279 280 281 282 283 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!